IND


Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms, Wikipedia.

IND

On drawings, abbr. for “industrial.”
References in periodicals archive ?
Jolanna Erickson, NALP Ball State University Muncie, Ind.
Robin Anthony Coombes, Ind John Terence Haram, Ind Doreen Purvis, Labour Christopher Taylor, Conservative Christopher Harold Thornton, BNP
Saeed PMLN, ward 3- Sher Mohammad PMLN, ward 4- Wajahat ind , ward 5-Shahid Mehmood PTI , ward 6- Manzoor Elahi PMLN , ward 7- Miskeen Khan PMLN , ward 8- Hafiz Nazeer Ahmad ind , ward 9- Shahid Hussain PTI , ward 10: Ghulam Mohammad ind and ward 11- M.
His story: An 11th-round draft pick out of Oklahoma State in 2002, Brown led a late-season surge in 2003 that helped South Bend, Ind.
Achievement of this milestone not only strengthens our data package, but it allows us to continue to move forward towards filing an IND," said Woodruff Emlen, M.
Inspire expects to submit the IND application for intranasal epinastine in the third quarter of 2006 and begin Phase 2 clinical testing by year-end 2006.
William Caldwell, CEO of Advanced Cell Technology said, "I am very proud of our scientific team for their accomplishments in pushing each of these therapeutic programs forward towards IND submission.
We are also on track to file an IND for SGN-35 in mid-2006 for the treatment of CD30-positive hematologic malignancies.
The objectives of the Phase I clinical protocol submitted with the IND are to evaluate the safety, pharmacokinetics and tolerability of IT-101 in humans.
Under the IND for OxyQD(TM), which was submitted for FDA review in late December 2005, Elite will initiate its developmental program by conducting a pilot Phase I study using its sustained release formulation.
CepTor Corporation (OTC BB:CEPO), a development-stage biopharmaceutical company focusing on cell-targeted therapeutic products for neuromuscular and neurodegenerative diseases, announced that on January 12, 2006 it submitted an IND to the Food and Drug Administration (FDA) to gain permission to begin human trials in DMD patients with Myodur, the Company's muscle cell-targeted calpain inhibitor compound.
It is very gratifying to advance another AVANIR-discovered molecule into human trials with the strong IND package our development team delivered," said Eric Brandt, President and Chief Executive Officer at AVANIR Pharmaceuticals.